(Press-News.org) URBANA, Ill. -- The pathogen that causes bacterial spot is very good at what it does. Forming small lesions on the rinds of pumpkins, melons, cucumbers, and other cucurbits, it mars the fruits’ appearance and ushers in secondary pathogens that lead to rot and severe yield loss. The bacterium, Xanthomonas cucurbitae, is so successful that it has had no reason to evolve through time or space. That’s according to new University of Illinois Urbana-Champaign research characterizing the pathogen’s genetic diversity across the Midwest.
“Previously, we sequenced the Xanthomonas cucurbitae genome from a sample taken in New York in 1926. In our current study, we sequenced genomes of samples taken by our collaborators across the Midwest in 2012 and 2013. All of the genomes were really quite similar, greater than 99% identical, but one isolate from Michigan was 99.9% identical to that 1926 isolate. Our results show there's been very little pressure on this pathogen to evolve,” said Sarah Hind, assistant professor in the Department of Crop Sciences, part of the College of Agricultural, Consumer and Environmental Sciences (ACES) at Illinois.
The surprising result suggests the pathogen is a one-trick pony. It surges reliably under specific conditions — hot and wet — and lurks quietly in the background otherwise. But the genetic uniformity could be good news for breeders looking to develop resistant crops.
“If we were able to deploy a resistant plant population, then it should be pretty effective against what they would likely encounter, at least across the Midwest and probably much of the U.S., because there's not a lot of diversity in pathogen populations,” she said.
Hind says there’s currently no known resistance in commercially available cucurbit crops, but she and her collaborators found bacterial spot resistance in experimental pumpkin and squash lines in a 2021 study. Still, she says they’d need to screen a lot more varieties before breeding efforts for resistance could begin in earnest.
In addition to opening up potential opportunities for developing disease-resistant cucurbits, the findings could inform current and future management strategies. For example, Hind says bacterial spot isn’t particularly responsive to industry-standard copper antimicrobial sprays. Knowing more about the genetic capabilities of the pathogen could forecast whether such management strategies will be effective long-term.
The study, “Comparative genomics of Xanthomonas cucurbitae isolates collected from Midwestern United States pumpkin fields,” is published in Plant Pathology [DOI: 10.1111/ppa.13965]. The research was supported in part by the USDA National Institute of Food and Agriculture.
END
Pumpkin disease not evolving, could make a difference for management
2024-07-10
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome
2024-07-10
“[...] our results put the basis for the use of antioxidants supplementation in Down Syndrome patients to prevent liver-associated pathologies.”
BUFFALO, NY- July 10, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 12, entitled, “Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome.”
Down Syndrome (DS) is a common genetic disorder characterized by an extra copy of chromosome 21, leading to dysregulation of various metabolic pathways. Oxidative stress in DS is associated ...
Targeting ABC transporters in PDAC – past, present, or future?
2024-07-10
“[...] it is crucial for the future application of ABC transporter inhibitors [...] to develop a stratification protocol [...] to identify those PDAC patients who are most likely to benefit from chemosensitization induced by these inhibitors.”
BUFFALO, NY- July 10, 2024 – A new editorial paper was published in Oncotarget's Volume 15 on June 20, 2024, entitled, “Targeting ABC transporters in PDAC – past, present, or future?”
In this new editorial, Cecilia Bergonzini, Elisa Giovannetti and Erik ...
Machine learning models could enable earlier identification of at-risk children, aiding social workers and potentially improving outcomes, per Danish study of more than 100,000 children
2024-07-10
Machine learning models could enable earlier identification of at-risk children, aiding social workers and potentially improving outcomes, per Danish study of more than 100,000 children
###
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0305974
Article Title: Predictive risk modeling for child maltreatment detection and enhanced decision-making: Evidence from Danish administrative data
Author Countries: Denmark, France
Funding: Funding for this project was ...
Holiday season already? Anticipation might make time seem to fly
2024-07-10
Christmas or Ramadan might seem to come around more quickly each year, for people who pay more attention to time, are more forgetful of plans, and love a good holiday. A research team led by Ruth Ogden of Liverpool John Moores University, UK, and Saad Sabet Alatrany of Imam Ja'afar Al-Sadiq University, Iraq, published these findings in the open-access journal PLOS ONE on July 10, 2024. They suggest this could mean that someone’s experience of time is shaped not only by what they’ve done, but what is left to do.
“Christmas seems to come quicker each year,” is a staple of small talk. But the ...
Perceived warmth, competence predict callback decisions in meta-analysis of hiring experiments
2024-07-10
Perceived warmth and competence predict the influence of race, gender and age on callback decisions, suggesting social perceptions might underlie such hiring bias. The meta-analysis of North American correspondence studies is published July 10, 2024 in the open-access journal PLOS ONE by Carina Hausladen from the California Institute of Technology and ETH Zürich, Marcos Gallo from the California Institute of Technology, and colleagues.
In the labor market, applicants from marginalized groups continue to face disparate treatment. To ...
Microproteins found in tumors could lead to cancer vaccines
2024-07-10
A study led by the Hospital del Mar Research Institute, with Cima University of Navarra and Pompeu Fabra University, has identified a group of small molecules exclusive to liver tumors that could be key to developing cancer vaccines. These are microproteins, very small proteins expressed only by tumor cells. This can result in the activation of immune cells against the tumor. The study is published in Science Advances.
By integrating data from tumors and healthy tissue from over one hundred liver cancer ...
Mount Sinai and City of Hope scientists first to demonstrate a combination treatment can increase human insulin-producing cells in vivo
2024-07-10
NEW YORK and LOS ANGELES — In preclinical studies, a team of researchers from Mount Sinai Health System in New York City and City of Hope in Los Angeles report new findings on a therapeutic combination that regenerated human insulin-producing beta cells, providing a possible new treatment for diabetes. The findings were published today in Science Translational Medicine.
This work, led by Andrew F. Stewart, MD, Irene and Dr. Arthur M. Fishberg Professor of Medicine and Director of the Mount Sinai Diabetes, Obesity ...
City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-producing cells in vivo
2024-07-10
LOS ANGELES and NEW YORK — In preclinical studies, a team of researchers from City of Hope® in Los Angeles and Mount Sinai Health System in New York reports new findings on a therapeutic combination that regenerated human insulin-producing beta cells, providing a possible new treatment for diabetes. The findings were published today in Science Translational Medicine.
This work, led by Andrew F. Stewart, M.D., Irene and Dr. Arthur M. Fishberg Professor of Medicine and Director of the Mount Sinai Diabetes, Obesity and Metabolism Institute, began at the Icahn School of Medicine at Mount Sinai in 2015. The studies were a team effort. Adolfo ...
New Co-STAR receptor shows promise treating cancers in laboratory study
2024-07-10
Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Laboratory and Bloomberg~Kimmel Institute for Cancer Immunotherapy have designed a novel type of cell to recognize and fight cancer.
To produce the cells, called Co-STAR (Co-stimulatory Synthetic T-cell receptor and Antigen Receptor) cells, the researchers combined genetic components of four types of cells that the body normally uses to defend against invaders to make ...
Novel genome editing approach restores hearing in adult preclinical models with genetic deafness
2024-07-10
The study also looked at safety of the AAV-mediated genome editing approach and found it had a good safety profile that includes little off-target effect and no detectable long-term integration of the AAV vector in the genome. “Our research suggested minimal potential risk and supports the feasibility of future clinical applications in humans,” said Wenliang Zhu, PhD, and physician-scientist Wan Du, MD, PhD, members of Chen’s lab at Mass Eye and Ear and first authors on the paper.
The study, led by Zheng-Yi Chen, DPhil, an associate scientist in the Eaton-Peabody Laboratories at Mass Eye and Ear (a member of the ...